Member Info for oscar22

Dallo,

I agree with you and this would be the worst moment to sell, in fact I bought another £8000 this morning. I remember what happened last time we got this low…it went up over 300% and apart from the dilution, we are way better of now so I will just wait for the study results. GLA

See below from my HSBC account - £18,659.50 Executed - waiting for another trade of £1300

"The date indicated below will automatically change to reflect the settlement date.
* Date Type
Share
Quantity Price Amount Status *
Order Ref.
* 12 Aug 2021 Buy IMM 222,000 8.400p £18,659.50 *Executed *
* P-341139 * IMMUPHARMA PLC * *

* *
*

Ridiculous low price - just added £20,000 - looking forward to the PK study results. GLA

As I quoted before “The stock market is a device to transfer money from the impatient to the patient.” - this will go through so more than happy to hold and enjoy massive gains. I also would love to see people getting cured by Lupuzor! Well done ImmuPharma and Avion!

Btw, where are all those losers that were saying we were just dreaming? Laughing at them now!

@ Dallo and Nolupus,
Have any of you thought of a possible takeover based on the recent news?
Why Dr Zimmer agreed not to sale any of his shares in the next 3 years? FDA still hasn’t delivered its final decision but I think IMM and Avion know already what’s gonna happened hence all these recent changes.
Today ‘s trading day was painful but I couldn’t see any major sale-off here:
Today # of Trades 95
Vol Sold 1,633,933
Vol Bought 1,181,613

When a clown like you is exposed as a fool has no other option but to insult and run away from the argument. Why you don’t email Lisa tomorrow to confirm my stake in the company and reply to my questions? You are just an ignorant with a big mouth. 3p...in your dreams!

I owe less than 1% due to the dilution. Please email Lisa at ImmuPharma tomorrow with your ID and prove that you hold shares at IMM and I will call her to authorised her to confirm this information to you on the condition that you will admit that you are a just a fool with a big mouth who just talk nonesense in this board. You still haven’t replied to my questions. I’m a serious investor not s clown like you.

Dallo - thank you for your input and constructive comments. I also mentioned some of these points on my previous posts. Let’s not forget that 62 patients were previously enrolled in the study throughout US and Europe completing a 24-week follow-up treatment period and that the primary endpoint was successfully achieved confirming the safety profile of Lupuzor with no serious adverse events reported so I do not see why the FDA would not allow Avion to go ahead with the international phase III trial of a safe product.

ALB1 - I still have all my shares and I have not sold any of them, I can authorise you to verify this information with IMM on the condition that you will share this information here on the board so you will just look like a lier. I have always been transparent with my holdings. Yesterday I even increased my stake here and I can also prove it, I bought an additional £25,0000 worth of shares and acquired them at 9.06 and 9.0. I personally believe in what IMM is doing, its potential as a small biotech company, the direction that is heading and I also believe that the SP will suffer a positive correction as soon as FDA makes the announcement that most of us are waiting for. The price in November 2019 reached 34p at its highest and in my opinion, we are in a much better position now so I do believe the SP is quite undervalued hence a strong buy. Just do your own research and compare the SP with other small biotech companies in similar positions.

Now, you still have not provided any information about the short position that you mentioned in your previous post and why the share price will hit 3p?

Also, what is your interest in this share, do you have any holdings here?

kevgrimmley - write properly otherwise do not write anything at all.

This board is plenty of people that should not be allowed to write baseless and nonsense comments whenever they want.

ALB1 - there is no short position opened against IMM's share price so explain your groundless and misleading comment.

So I just managed to buy another 240,000 at 9.06 and placed an additional order. They should come up on the buying records soon. Good luck everyone!

I also tried to buy but the market is not selling. Placed an order this morning for 250,000 at 9.06 but still nothing happens so let’s see what happens at the end of the day.

Placed an order for 250k at 9.1 to increase my stake here before things move forward so let's see if the market fills it up before the close.

below the link to an interview by Navid Malik at The Life Sciences Division with Katie Pilbeam at Proactive Investors

This has gone live this morning.





https://www.proactiveinvestors.co.uk/companies/news/941682/immupharma-the-life-sciences-division-s-dr-malik-says-shares-are--oversold--reiterating-buy-rating-941682.html

Over 2 million of shares have been bought today. Looking good!

#of Trades 113
Vol Sold 318,472
Vol Bought 2,093,072

# of Trades 108
Vol Sold 313,472
Vol Bought 2,079,072

Aventador

Yes, it is from this morning, I got an email from Lisa. Please email ImmuPharma to get a copy of the full note. It’s very interesting! Good luck.

Please find below a note issued this morning from Navid Malik, analyst at The Life Sciences Division



Summary:



“ImmuPharma recently announced an update on the FDA meeting with Avion, ImmuPharma’s

partner for Lupuzor™, on 4 December 2020 (Type ‘A’ meeting request). Based on the positive

guidance and feedback from FDA, there is now a clear regulatory pathway to commence the

Phase III trial in H2 2021, fully funded by Avion. As part of this feedback, Avion and ImmuPharma

will develop and validate a bioanalytical assay in order to confirm the unique pharmacokinetic

profile of Lupuzor™. This will be presented at the final guidance meeting between Avion and the

FDA in Q2 as well as confirming the previously submitted data on study design, clinical end points

and the pathway to approval. ImmuPharma is also having a new batch of Lupuzor™

manufactured ready for use in the Phase III clinical trial. Given the strengthened balance sheet

position following the £6.5m placing in September 2020, a cash runway to end 2023, a fully funded

Phase III trial (by Avion with a US$25m investment) in an attractive market, and poorly met

medical need, we believe the shares are oversold and reiterate our BUY rating and TP of 100p.”

Hi Dallo,

I agree with you, we will get there! We just need to be a little bit more patient for the last push! I’m happy that you put up some information about the Avion Group because some ignorant people just talk because they have a big mouth without having any knowledge about solid facts. I will not be selling any shares any time soon because I’m feeling positive and confident that things will turn around in our favour! Good luck!

In my opinion, regardless of the recent delay things are looking great and it appears that IMM is making slow but solid progress to get the P3 started soon following the constructive guidance received by the FDA. Good luck to everyone!

https://youtu.be/0yoEn6J_DqI